Literature DB >> 29022231

Calcium Channel Blockers for the Clinical Management of Hypertension.

Massimo Volpe1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29022231     DOI： 10.1007/s40292-017-0233-0

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN： 1120-9879


× No keyword cloud information.
  33 in total

Review 1.  Antihypertensive therapy and new onset diabetes.

Authors:  Franz H Messerli; Ehud Grossman; Gastone Leonetti
Journal:  J Hypertens       Date:  2004-10       Impact factor: 4.844

2.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

3.  Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.

Authors:  R E Schmieder; P Martus; A Klingbeil
Journal:  JAMA       Date:  1996-05-15       Impact factor: 56.272

Review 4.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

5.  Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice.

Authors:  Giovanni Corrao; Federica Nicotra; Andrea Parodi; Antonella Zambon; Franca Heiman; Luca Merlino; Ida Fortino; Giancarlo Cesana; Giuseppe Mancia
Journal:  Hypertension       Date:  2011-08-08       Impact factor: 10.190

6.  Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Authors:  Henry R Black; William J Elliott; Gregory Grandits; Patricia Grambsch; Tracy Lucente; William B White; James D Neaton; Richard H Grimm; Lennart Hansson; Yves Lacourciere; James Muller; Peter Sleight; Michael A Weber; Gordon Williams; Janet Wittes; Alberto Zanchetti; Robert J Anders
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

7.  A randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension.

Authors:  Matthew R Weir; Henry A Punzi; John M Flack; Kathy A Stoakes; Kathleen J Chavanu; Wei Li; Robert Dubiel
Journal:  Postgrad Med       Date:  2011-01       Impact factor: 3.840

8.  Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study.

Authors:  Robert Lins; Yves Haerden; Caroline de Vries
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-03

9.  Antihypertensive effect of barnidipine 10 mg or amlodipine 5 to 10 mg once daily in treatment-naive patients with essential hypertension: A 24-week, randomized, open-label, pilot study.

Authors:  Giuseppe Rossetti; Samuele Pizzocri; Francesco Brasca; Marta Pozzi; Laura M Beltrami; Giovanni B Bolla; Roberta Famiani; Barbara Caimi; Stefano Omboni; Fabio Magrini; Stefano Carugo
Journal:  Curr Ther Res Clin Exp       Date:  2008-06

Review 10.  Development of heart failure in recent hypertension trials.

Authors:  Giuliano Tocci; Sebastiano Sciarretta; Massimo Volpe
Journal:  J Hypertens       Date:  2008-07       Impact factor: 4.844
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.